Eloxx Pharmaceuticals Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Eloxx Pharmaceuticals Inc.
Former names: Sevion Therapeutics, Inc. Senesco Technologies Inc Nava Leisure USA Inc
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Delaware
Headquarters city: Arlington
Headquarters state / province: Massachusetts
Headquarters country: United States
Fiscal year end: December
Ticker symbol: ELOX
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001035354
EIN: 84-1368850

Board of directors

Follow this board

Alan Edmund Walts · Director
Since 2023
Geno J. Germano · Director
Since 2026
Lindsay Androski · Director
Since 2023
Nina S. Kjellson · Director
Since 2026
Stephen W. Webster · Director
Since 2026
Steven D. Rubin · Director Overboarded
Since 2023
Sumit Aggarwal · Director · President and CEO
Since 2023
Tomer Kariv · Director
Since 2023

Chief executives

Sumit Aggarwal · PRESIDENT AND CEO

Dates unknown

Director election results

Annual meeting of June 22, 2023. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

6 of this board's directors also sit on 12 other boards. 11 are in the same sector.

Shared director Other board Same sector

Entera Bio Ltd. Same sector
via Geno J. Germano and Steven D. Rubin
Arbutus Biopharma Corporation Same sector
via Lindsay Androski
Cocrystal Pharma Inc. Same sector
via Steven D. Rubin
Cullinan Therapeutics Inc. Same sector
via Stephen W. Webster
Harmony Biosciences Holdings Inc. Same sector
via Geno J. Germano
Keros Therapeutics Inc. Same sector
via Tomer Kariv
NextCure Inc. Same sector
via Stephen W. Webster
Niagen Bioscience Inc. Same sector
via Steven D. Rubin
OPKO Health Inc. Same sector
via Steven D. Rubin
Precision BioSciences Inc. Same sector
via Geno J. Germano
Red Violet Inc.
via Steven D. Rubin
Tyra Biosciences Inc. Same sector
via Nina S. Kjellson

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Jun 10, 2026	Domicilium Real Estate Fund III LP 10% owner	Other	+238,422	—	—
Jun 10, 2026	Domicilium Real Estate Fund III LP 10% owner	Other	+361,578	—	—
May 27, 2026	Domicilium Real Estate Fund III LP 10% owner	Other	−113,636	—	—
May 27, 2026	Coastlands Capital LP 10% owner	Other	−1,250,000	—	—
Feb 28, 2026	Sumit Aggarwal Director, Officer (President and CEO), 10% owner	Option exercise	+260,946	$0.15	$39,142
Jan 24, 2026	Steven D. Rubin Director	Option exercise	+1,875	—	—
Jan 24, 2026	Alan Edmund Walts Director	Option exercise	+1,875	—	—
Jan 24, 2026	Sumit Aggarwal Director, Officer (President and CEO), 10% owner	Option exercise	+15,000	—	—
Sep 19, 2025	Sumit Aggarwal Director, Officer (President and CEO), 10% owner	Grant or award	+1,000,000	—	—
Aug 14, 2025	Sumit Aggarwal Director, Officer (President and CEO), 10% owner	Option exercise	+196,880	—	—
Jan 24, 2025	Sumit Aggarwal Director	Option exercise	+30,000	—	—
Jan 24, 2025	Steven D. Rubin Director	Option exercise	+3,750	—	—
Jan 24, 2025	Lindsay Androski Director	Option exercise	+3,750	—	—
Jan 24, 2025	Alan Edmund Walts Director	Option exercise	+3,750	—	—
Oct 16, 2024	Alan Edmund Walts Director	Grant or award	+12,000	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Eloxx Pharmaceuticals Inc.

Who is the CEO of Eloxx Pharmaceuticals Inc.?

Sumit Aggarwal is Eloxx Pharmaceuticals Inc.'s PRESIDENT AND CEO.

How many directors are on Eloxx Pharmaceuticals Inc.'s board?

Eloxx Pharmaceuticals Inc.'s board has 8 directors: Alan Edmund Walts, Geno J. Germano, Lindsay Androski, Nina S. Kjellson, Stephen W. Webster, Steven D. Rubin, Sumit Aggarwal and Tomer Kariv.

How is Eloxx Pharmaceuticals Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="eloxx-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.